Back to AZN Stock Lookup

AZN Related Analyst Ratings

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 3, 2013 09:59 AM Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)

Apr 2, 2013 08:05 AM JPMorgan Upgrades AstraZeneca (AZN) to Neutral

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Mar 22, 2013 07:26 AM Natixis Upgrades AstraZeneca (AZN) to Neutral

Dec 14, 2012 07:09 AM Societe Generale Downgrades AstraZeneca (AZN) to Sell

Sep 19, 2012 07:21 AM Exane BNP Paribas Upgrades AstraZeneca (AZN) to Neutral

Sep 12, 2012 09:23 AM Leerink Swann Maintains an 'Outperform' on Teva Pharma (TEVA); Review with Patent Specialist

Sep 10, 2012 07:44 AM Leerink Swann Starts Salix Pharmaceuticals (SLXP) at Market Perform; N-T Catalyst Absent, Long-Term Fundamentals Intact

Sep 10, 2012 06:52 AM BofA/Merrill Lynch Downgrades AstraZeneca (AZN) to Underperform

Sep 7, 2012 06:51 AM Morgan Stanley Upgrades AstraZeneca (AZN) to Equalweight

Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM

Aug 20, 2012 06:48 AM JPMorgan Downgrades AstraZeneca (AZN) to Underweight

Aug 15, 2012 10:31 AM UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors

Aug 2, 2012 08:37 AM Nomura Securities Reiterates a 'Reduce' on AstraZeneca (AZN); Overpayment Risk in Deal with Bristol Myers (BMY)

Jul 30, 2012 10:15 AM Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Hold; Concerns on Lack of Clarity with Relistor

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 2, 2012 03:10 PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag

Jun 5, 2012 07:38 AM Jefferies Discusses Array BioPharma (ARRY) After Detailed Selumetinib Ph2 Data in NSCLC

May 10, 2012 09:13 AM SocGen Starts GSK, NVS, SNY at Buy, AZN at Hold

May 8, 2012 09:14 AM UPDATE - Canaccord Genuity Downgraded Ardea Biosciences (RDEA) To 'Hold'; Q1 Is Non-Event In Light Of Acquisition By AZN

May 1, 2012 02:39 PM Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official

May 1, 2012 07:18 AM BofA/Merrill Lynch Upgrades AstraZeneca (AZN) to Neutral

Apr 30, 2012 08:16 AM JPMorgan Upgrades AstraZeneca (AZN) to Neutral

Apr 23, 2012 09:54 AM Brean Murray Carret & Co. Downgrades Ardea Biosciences (RDEA) to Hold; AstraZeneca (AZN) Steps In

Mar 28, 2012 12:35 PM Analysts Expecting Higher Bids for Amylin (AMLN)

Feb 7, 2012 09:27 AM BofA/Merrill Lynch Downgrades AstraZeneca (AZN) to Underperform

Feb 2, 2012 08:53 AM Canaccord Genuity Reiterates a 'Buy' on Impax Labs (IPXL); Raising Estimates on Deal Announcement; Sentiment Starting to Shift

Feb 2, 2012 08:06 AM Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost

Jan 6, 2012 10:58 AM Needham & Company Maintains a 'Hold' on Targacept (TRGT); Sidelined Until TC5214 Phase 3 Story in Depression is Fully Resolved

Jan 5, 2012 08:24 AM JPMorgan Downgrades AstraZeneca (AZN) to Underweight

Nov 8, 2011 12:28 PM Needham & Company Downgrades Targacept (TRGT) to Hold

Nov 7, 2011 01:09 PM Morgan Stanley Raises Glaxo (GSK) to Equalweight, Downgrades AstraZeneca (AZN) by Two Notches to Underweight

Nov 7, 2011 11:58 AM Morgan Stanley Downgrades AstraZeneca (AZN) to Underweight

Oct 19, 2011 12:14 PM Jefferies on Abbott (ABT) Split: Pharma Unit Could Be Worth $29/Share, Medical Unit $32/Share

Sep 22, 2011 03:10 PM Needham & Company Maintains a 'Buy' on Targacept (TRGT); Expect Continued Positive Results from AZN Collaboration

Jul 22, 2011 07:54 AM BofA/Merrill Lynch Downgrades AstraZeneca (AZN) to Neutral

Jul 13, 2011 01:11 PM Barclays on U.S. Diagnostics: FDA Issues draft guidance on companion diagnostics; Positive read for QGEN

Jul 12, 2011 01:57 PM Barclays on U.S. Retail Hardlines: Wag.com - Initial Take/Pricing Study on New Pet Supply E-commerce Site

Jun 20, 2011 10:20 AM Eli Lilly (LLY) Might Be M&A Target if Things Don't Shape Up

Jun 16, 2011 11:42 AM UPDATE - UBS Initiates Coverage on AutoZone (AZN) with a Neutral; Rolling Ahead, but at a Slower Pace

Jun 10, 2011 08:10 AM Barclays Slashes Rating on AstraZeneca (AZN) to Underweight

Jun 2, 2011 07:21 AM Jefferies Downgrades AstraZeneca (AZN) to Underperform

May 16, 2011 02:05 PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine

May 11, 2011 12:07 PM UBS Upgrades AstraZeneca (AZN) to Buy; Shares on the Move

May 6, 2011 08:57 AM UPDATE - Needham & Company Upgraded Targacept (TRGT) to Strong Buy; Valuation Attractive after Distraction of AstraZeneca TC-5619 Option Decision

Mar 10, 2011 07:59 AM Jefferies Cuts Price Target on POZEN Inc. (POZN) by 28.5%, Major Patent Risk

Mar 7, 2011 02:16 PM Barclays on Healthcare Services: Weekly Flu Clues Review

Mar 1, 2011 12:32 PM UBS Upgrades Sanofi-Aventis (SNY) to Buy, Downgrades AstraZeneca (AZN) to Neutral

Feb 2, 2011 01:20 PM Barclays Reiterates an 'Overweight' on Array BioPharma (ARRY); Reports FY2Q11, Data for MEK inhibitors in 2011

Back to AZN Stock Lookup